Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS)

Details for Australian Patent Application No. 2004268001 (hide)

Owner UniVax, LLC

Inventors Ghochikyan, Anahit; Agadjanyan, Michael G.

Agent FB Rice

Pub. Number AU-B-2004268001

PCT Pub. Number WO2005/021029

Priority 60/497,511 25.08.03 US

Filing date 25 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 22 April 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021029 Priority application(s): WO2005/021029

11 May 2006 Change of Name(s) of Applicant(s), Section 104

  Anahit Ghochikyan, Has no value - Entry Incomplete The name of the applicant has been changed to OncoMune

21 January 2010 Assignment before Grant

  OncoMune The application has been assigned to UniVax, LLC

22 April 2010 Application Accepted

  Published as AU-B-2004268001

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268012-Ophthalmic compositions for treating ocular hypertension

2004267997-Silver dihydrogen citrate compositions comprising a second antimicrobial agent